ADVERTISEMENT

77 Elektronika Kft. Launches Continuous Glucose Monitoring System

Manufacturing

Diabetics and their physicians will be able to get a more detailed picture of the body’s sugar metabolism thanks to a continuous monitoring system introduced this month by Hungarian medical equipment manufacturer 77 Elektronika Kft.

The launch of the GlucoMen Day continuous glucose monitor (CGM) system in Hungary is in cooperation with Italian company A. Menarini Diagnostics.

77 Electronika says the new system delivers real-time, continuous glucose monitoring via a sensor that takes a measurement every minute, 24 hours a day. It is compatible with a mobile application, meaning the data can also be shared with the patient’s doctor. That means both can gain insights into how, for example, eating, exercising, or certain medications affect an individual’s metabolism. The device can even warn the patient if dangerous values are detected, during sleep, for example.

The device differs from the traditional fingertip blood glucose measurement in that the former provides real-time, dynamic information on the rate and direction of glucose change. In contrast, a blood glucose meter provides only a brief “snapshot” of glucose levels.

The company says the sensor is placed under the surface of the skin painlessly (without a needle) using a simple device. Once in situ, it can help determine what causes significant changes in blood sugar levels and analyze what needs to be changed in the therapy. The real-time glucose readings it takes are automatically transmitted to a smartphone or monitor using a built-in data transmitter.

Danger Warning

The GlucoMen Day device is able to detect and notify when glucose levels reach the upper or lower end of the optimal target range (entering the hyper- or hypoglycaemic phase) and can even predict trend-based dangerous values and alert the user in good time.

77 Elektronika was the first manufacturer to make fingertip blood glucose monitoring widely available to diabetics in Hungary. The 100% Hungarian-owned firm, which owns and manufactures the Dcont blood glucose measuring product family, still plays a leading role in the Hungarian blood glucose measuring market.

The latest models in the Dcont family are the first in the world to allow near-laboratory level blood glucose measurement during home self-monitoring. The “smart” blood glucose meters can also be connected to a telemedicine system also developed by the company.

In April 2021, 77 Elektronika bucked the usual trend of foreign companies buying up Hungarian businesses when it acquired the German medical diagnostics firm Analyticon Biotechnologies AG, the second-largest manufacturer of reagent strips on the German market.

Sándor Zettwitz, co-owner and CEO of 77 Elektronika, said at the time, “We believe that there are very few examples of a Hungarian company buying a German company; the opposite is a lot more common. The acquisition of Analyticon AG is 77 Elektronika’s first foreign investment, and we are confident that we have taken a big step forward to ensure the security of the company’s operations,” he continued.

This article was first published in the Budapest Business Journal print issue of March 25, 2022.

ADVERTISEMENT

Czech economic confidence improves in May Analysis

Czech economic confidence improves in May

Ministers in new Orbán gov't sworn in Parliament

Ministers in new Orbán gov't sworn in

Spring’s allergy season - the heat is on Interview

Spring’s allergy season - the heat is on

Airport bus fare could rise to HUF 1,500 City

Airport bus fare could rise to HUF 1,500

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.